Cours Fennec Pharmaceuticals Inc Other OTC
Actions
CA31447P1009
Recherche biotechnologique et médicale
CA 2024 * | 58,64 M 53,12 M | CA 2025 * | 71,15 M 64,45 M | Capitalisation | 266 M 241 M |
---|---|---|---|---|---|
Résultat net 2024 * | 14 M 12,68 M | Résultat net 2025 * | 26 M 23,55 M | VE / CA 2024 * | 4,54 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 3,74 x |
PER 2024 * |
17,7
x | PER 2025 * |
10,5
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 84,7% |
Dernier transcript sur Fennec Pharmaceuticals Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 07/07/09 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 07/07/09 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 25/04/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 25/08/11 |
Khalid Islam
CHM | Chairman | 67 | 25/04/14 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 07/07/09 |
Varia. 1 janv. | Capi. | |
---|---|---|
+3,91% | 109 Md | |
+10,87% | 105 Md | |
+1,28% | 22,25 Md | |
-13,14% | 22,09 Md | |
-7,05% | 18,68 Md | |
-38,36% | 17,58 Md | |
-10,66% | 16,85 Md | |
+3,75% | 13,76 Md | |
+36,70% | 12,46 Md |